Actual bioavailability of divalproex sodium extended-release tablets and its clinical implications

Autor: Nicolás Ponce González, Omar Martín, Pietro Fagiolino, Antonio Malanga

Publikováno v: Journal of Epilepsy and Clinical Neurophysiology v.13 n.2 2007
Journal of epilepsy and clinical neurophysiology
Liga Brasileira de Epilepsia (LBE)
instacron:LBE
Journal of Epilepsy and Clinical Neurophysiology, Volume: 13, Issue: 2, Pages: 75-78, Published: JUN 2007

Divalproex sodium extended-release dosage form (divalproex-ER) has been promoted as innovative formulation for the treatment of epilepsy and manic disorders, and for migraine headache prevention, with the advantage of being dosing once a day. Due to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c84a52bb6a5798bd3b83e965c3b0e7
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492007000200007